What is the treatment for a fungal infection of the hands?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Fungal Infection of the Hands

For dermatophyte infections of the hands (tinea manuum), topical antifungal therapy with azoles or allylamines for 2-4 weeks is the first-line treatment, while Candida infections require itraconazole 200 mg daily for at least 4 weeks as first-line systemic therapy, with fluconazole as an alternative. 1

Determining the Type of Fungal Infection

The causative organism must be identified before initiating treatment, as dermatophytes and Candida species require different therapeutic approaches 1, 2:

  • Dermatophyte infections (tinea manuum): Look for dry, scaly patches with raised borders, often unilateral presentation, and involvement of palmar surfaces 2, 3
  • Candida infections: Typically present with moist, erythematous interdigital spaces, paronychia, or involvement in patients with occupational water exposure (e.g., dishwashers, healthcare workers) 1, 4
  • Confirm diagnosis with potassium hydroxide (KOH) preparation of skin scrapings showing hyphae (dermatophytes) or budding yeasts (Candida) 2, 3

Treatment for Dermatophyte Infections (Tinea Manuum)

Topical Therapy (First-Line)

Fungicidal allylamines are preferred over fungistatic azoles because they kill fungi rather than just inhibiting growth, allowing shorter treatment courses and reducing recurrence rates 5:

  • Terbinafine cream: Apply once daily for 1-2 weeks 5, 3
  • Naftifine or butenafine cream: Apply once daily for 1-2 weeks 5
  • Alternative azoles (if allylamines unavailable): Miconazole, clotrimazole, or ketoconazole applied twice daily for 2-4 weeks 2, 4, 3

Continue treatment for at least one week after clinical clearing to prevent recurrence 3

Systemic Therapy (For Extensive or Resistant Cases)

When topical therapy fails or infection is widespread 4, 3:

  • Terbinafine 250 mg daily for 2-4 weeks 1
  • Itraconazole 200 mg daily for 2-4 weeks 2
  • Griseofulvin 500 mg daily (less preferred due to longer treatment duration): 4-8 weeks 6, 2

Treatment for Candida Infections of the Hands

Without Nail Involvement

Itraconazole is the first-line systemic treatment for Candida hand infections 1:

  • Itraconazole 200 mg daily for minimum 4 weeks 1
  • Alternative: Fluconazole 200-400 mg daily for minimum 4 weeks if contraindications to itraconazole exist 1

Topical azoles can be used for mild interdigital Candida infections 4:

  • Miconazole or clotrimazole cream twice daily for 2-4 weeks 4

With Nail Involvement (Candida Onychomycosis)

Itraconazole remains first-line due to shorter treatment duration and better cost-effectiveness 1:

  • Itraconazole 200 mg daily for 4 weeks (fingernails) 1
  • Alternative pulse therapy: Itraconazole 400 mg daily for 1 week per month 1
  • Fluconazole alternatives: 50 mg daily or 300 mg weekly for 4 weeks (fingernails) 1

Important caveat: Terbinafine requires prolonged courses (48 weeks) for Candida onychomycosis with only 70-85% cure rates, making it less practical than itraconazole 1

Addressing Predisposing Factors

Elimination of predisposing factors is essential for cure and prevention of relapse 1, 4:

  • For occupational exposure: Recommend protective gloves, frequent hand drying, and work practice modifications 1
  • For Raynaud phenomenon: Emphasize keeping hands warm 1
  • For diabetes or immunosuppression: Optimize underlying condition management 7

Special Considerations and Pitfalls

Common pitfalls to avoid 5, 3:

  • Stopping treatment when skin appears healed: Patients typically discontinue therapy after 1 week when symptoms resolve, but this leads to recurrence with fungistatic agents. Emphasize completing the full course 5
  • Mistaking secondary bacterial colonization for primary infection: In subcutaneous fungal infections (rare but serious), bacterial superinfection may mask the underlying fungal etiology, delaying appropriate antifungal therapy 7
  • Using topical therapy alone for nail infections: Topical agents penetrate poorly through nail plates and are generally ineffective for onychomycosis 5

For deep or subcutaneous infections (e.g., sporotrichosis from rose thorn injuries): These require systemic antifungal therapy combined with possible surgical debridement and have significant morbidity 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Topical treatment of common superficial tinea infections.

American family physician, 2002

Research

Topical therapy for fungal infections.

American journal of clinical dermatology, 2004

Research

Fungal infections of the hand.

Hand clinics, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.